Executive Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.27M Buy
20,422
+7,424
+57% +$691K 0.1% 129
2024
Q3
$2.04M Sell
12,998
-3,096
-19% -$477K 0.16% 114
2024
Q2
$2.42M Sell
16,094
-6,639
-29% -$796K 0.44% 48
2024
Q1
$1.67M Sell
22,733
-5,408
-19% -$446K 0.15% 113
2023
Q4
$2.22M Buy
28,141
+6,928
+33% +$418K 0.21% 94
2023
Q3
$1.16M Buy
21,213
+6,691
+46% +$482K 0.12% 118
2023
Q2
$1.22M Buy
+14,522
New +$1.11M 0.13% 116

Other funds holding TMDX

Executive Wealth Management's TMDX Position: Q4 2024 in Review

Executive Wealth Management increased its Transmedics (TMDX) stake by 57% in Q4 2024, buying an estimated $691K and bringing the position to 20,422 shares worth $1.27M. The position accounts for 0.1% of the portfolio, ranked #129.

Executive Wealth Management first reported a position in TMDX in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.42M in Q2 2024. 314 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Executive Wealth Management held 20,422 shares of Transmedics worth $1.27M as of Q4 2024.
  • Executive Wealth Management bought 7,424 Transmedics shares in Q4 2024, an estimated $691K.
  • Transmedics made up 0.1% of Executive Wealth Management's portfolio in Q4 2024, its #129 holding.
  • Executive Wealth Management first reported a position in Transmedics in Q2 2023 and has held it in 7 quarters since.
  • Executive Wealth Management's Transmedics position peaked at $2.42M in Q2 2024.
  • 314 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.